Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 13/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP3A5 | P20815 | 2/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26645489 | 0.91 | MEN1 (0.44) | GRM5NR1H2POLBMEN1KMT2A | |
| SCHEMBL26645025 | 0.87 | CFTR (0.44) | GRM5NR1H2MEN1KMT2AGPR119 | |
| SCHEMBL30622995 | 0.87 | CFTR (0.44) | GRM5NR1H2MEN1KMT2AGPR119 | |
| SCHEMBL26645578 | 0.86 | GRM5 (0.50) | GRM5CYP3A4CYP3A5NR1H2POLB | |
| SCHEMBL16711314 | 0.86 | GRM5 (0.50) | GRM5NR1H2KCNH2 | |
| SCHEMBL30623007 | 0.85 | MEN1 (0.41) | GRM5NR1H2POLBMEN1KMT2A | |
| SCHEMBL26645632 | 0.85 | CFTR (0.44) | GRM5NR1H2MEN1KMT2A | |
| SCHEMBL30622947 | 0.85 | CFTR (0.44) | GRM5NR1H2MEN1KMT2A | |
| SCHEMBL16711195 | 0.83 | GRM5 (0.50) | GRM5NR1H2 | |
| SCHEMBL24277112 | 0.83 | GRM5 (0.44) | GRM5NR1H2MEN1KMT2AESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519265-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | Bayer Aktiengesellschaft (DE) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023213882-A1 | IRREVERSIBLE MUTEGFR INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-11-09 | — | — | WO | disclosed |